CPIX ROE | Cumberland Pharmaceuticals Inc.

CUMBERLAND PHARMACEUTICALS INC ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

CUMBERLAND PHARMACEUTICALS INC roe for the quarter ending 2026-06-30 was -63.83%, a change of -53.24% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roe for the quarter ending 2026-03-31 was -34.66%, a change of -23.10% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roe for the quarter ending 2025-12-31 was -11.56%, a change of 17.19% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roe for the quarter ending 2025-09-30 was -12.90%, a change of 31.52% year-over-year.
CUMBERLAND PHARMACEUTICALS INC roe for fiscal 2025 was -11.56%, a change of 17.19% from fiscal 2024.
CUMBERLAND PHARMACEUTICALS INC roe for fiscal 2024 was -28.74%, a change of -7.28% from fiscal 2023.
CUMBERLAND PHARMACEUTICALS INC roe for fiscal 2023 was -21.46%, a change of -5.98% from fiscal 2022.
CUMBERLAND PHARMACEUTICALS INC roe for fiscal 2022 was -15.48%, a change of -7.25% from fiscal 2021.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical ROE

Date	ROE	Net income 12 month	Net income 3 month	Shareholder equity
2026-06-30	-63.83%	-$10.92M	-$4.28M	$17.11M
2026-03-31	-34.66%	-$7.38M	-$3.29M	$21.3M
2025-12-31	-11.56%	-$2.84M	-$1.41M	$24.54M
2025-09-30	-12.90%	-$3.33M	-$1.94M	$25.8M
2025-06-30	-10.59%	-$2.93M	-$740.74K	$27.68M
2025-03-31	-11.56%	-$3.28M	$1.26M	$28.34M
2024-12-31	-28.74%	-$6.48M	-$1.90M	$22.55M
2024-09-30	-44.42%	-$10.87M	-$1.54M	$24.47M
2024-06-30	-39.86%	-$10.38M	-$1.09M	$26.03M
2024-03-31	-30.96%	-$8.42M	-$1.95M	$27.19M
2023-12-31	-21.46%	-$6.28M	-$6.29M	$29.26M
2023-09-30	-6.80%	-$2.43M	-$1.05M	$35.66M
2023-06-30	-4.85%	-$1.78M	$872.20K	$36.84M
2023-03-31	-11.08%	-$3.99M	$192.18K	$36.05M
2022-12-31	-15.48%	-$5.57M	-$2.44M	$35.97M
2022-09-30	-17.94%	-$6.98M	-$408.64K	$38.89M
2022-06-30	-19.45%	-$7.62M	-$1.34M	$39.2M
2022-03-31	-12.40%	-$5.06M	-$1.39M	$40.79M
2021-12-31	-8.23%	-$3.51M	-$3.85M	$42.6M
2021-09-30	-1.17%	-$543,666.00	-$1.06M	$46.65M
2021-06-30	0.06%	$29,875.00	$1.23M	$47.81M
2021-03-31	-4.52%	-$2.12M	$166.83K	$46.88M
2020-12-31	-7.12%	-$3.34M	-$883.78K	$46.87M
2020-09-30	-7.14%	-$3.42M	-$481.74K	$47.84M
2020-06-30	-10.10%	-$4.89M	-$918.27K	$48.41M
2020-03-31	-9.07%	-$4.52M	-$1.06M	$49.84M
2019-12-31	-6.93%	-$3.54M	-$960.71K	$51.09M
2019-09-30	-9.28%	-$4.8M	-$1.95M	$51.71M
2019-06-30	-8.36%	-$4.49M	-$549.51K	$53.69M
2019-03-31	-8.44%	-$4.66M	-$73.88K	$55.19M
2018-12-31	-12.53%	-$6.96M	-$2.22M	$55.57M
2018-09-30	-9.57%	-$5.54M	-$1.64M	$57.94M
2018-06-30	-7.78%	-$4.64M	-$720.69K	$59.67M
2018-03-31	-14.92%	-$9.08M	-$2.38M	$60.87M
2017-12-31	-12.48%	-$7.98M	-$800.54K	$63.92M
2017-09-30	-12.21%	-$7.93M	-$743.03K	$64.92M
2017-06-30	-10.65%	-$7.08M	-$5.16M	$66.49M
2017-03-31	-2.72%	-$1.97M	-$1.27M	$72.21M
2016-12-31	-1.29%	-$944,683.00	-$749.69K	$73.12M
2016-09-30	-0.06%	-$43,930.00	$106.17K	$74.42M
2016-06-30	-0.03%	-$23,483.00	-$48.04K	$74.37M
2016-03-31	0.57%	$430,559.00	-$253.11K	$75.32M
2015-12-31	0.95%	$729,951.00	$151.06K	$76.82M
2015-09-30	1.61%	$1.25M	$126.61K	$77.54M
2015-06-30	2.37%	$1.87M	$407.40K	$78.7M
2015-03-31	2.75%	$2.18M	$46.28K	$79.34M
2014-12-31	3.00%	$2.42M	$668.91K	$80.75M
2014-09-30	0.31%	$254,447.00	$745.92K	$80.89M
2014-06-30	-1.62%	-$1.31M	$722.57K	$80.73M
2014-03-31	-3.39%	-$2.67M	$286.32K	$78.96M
2013-12-31	-2.65%	-$2.1M	-$1.50M	$79.29M
2013-09-30	1.48%	$1.2M	-$819.94K	$80.93M
2013-06-30	4.69%	$3.89M	-$639.02K	$82.87M
2013-03-31	7.38%	$6.27M	$854.71K	$85.03M
2012-12-31	6.83%	$5.84M	$1.81M	$85.57M
2012-09-30	5.94%	$4.95M	$1.87M	$83.33M
2012-06-30	5.92%	$4.93M	$1.74M	$83.21M
2012-03-31	6.55%	$5.36M	$423.21K	$81.85M
2011-12-31	6.83%	$5.66M	$911.66K	$82.84M
2011-09-30	6.69%	$5.58M	$1.85M	$83.46M
2011-06-30	5.83%	$4.74M	$2.18M	$81.43M

Annual ROE

Date	ROE	Net income 12 month	Shareholder equity
2025-12-31	-11.56%	-$2.84M	$24.54M
2024-12-31	-28.74%	-$6.48M	$22.55M
2023-12-31	-21.46%	-$6.28M	$29.26M
2022-12-31	-15.48%	-$5.57M	$35.97M
2021-12-31	-8.23%	-$3.51M	$42.6M
2020-12-31	-7.12%	-$3.34M	$46.87M
2019-12-31	-6.93%	-$3.54M	$51.09M
2018-12-31	-12.53%	-$6.96M	$55.57M
2017-12-31	-12.48%	-$7.98M	$63.92M
2016-12-31	-1.29%	-$944,683.00	$73.12M
2015-12-31	0.95%	$731,351.00	$76.82M
2014-12-31	3.00%	$2.42M	$80.75M
2013-12-31	-2.65%	-$2.1M	$79.29M
2012-12-31	6.83%	$5.84M	$85.57M
2011-12-31	6.83%	$5.66M	$82.84M
2010-12-31	3.16%	$2.46M	$77.72M
2009-12-31	4.28%	$3.09M	$72.22M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aardvark Therapeutics, Inc. (AARD)	United States	$0.121B	-1.80
Coya Therapeutics, Inc. (COYA)	United States	$0.121B	-6.35
OnKure Therapeutics, Inc. (OKUR)	United States	$0.119B	-3.13
INOVIO PHARMACEUTICALS, INC. (INO)	United States	$0.125B	-1.35
IMMUNIC, INC. (IMUX)	United States	$0.127B	-1.88
Immuneering Corp (IMRX)	United States	$0.113B	-12.51
Quantum Cyber N.V. (QUCY)		$0.113B
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
BICYCLE THERAPEUTICS PLC (BCYC)		$0.112B	-1.56
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31